Therapeutic drugs that behave as mechanism-based inhibitors of cytochrome P450 3A4

Therapeutic drugs that behave as mechanism-based inhibitors of cytochrome P450 3A4

10.2174/1389200043335450

Saved in:

Bibliographic Details
Main Authors:	Zhou, S., Chan, E., Lim, L.Y., Boelsterli, U.A., Li, S.C., Wang, J., Zhang, Q., Huang, M., Xu, A.
Other Authors:	PHARMACY
Format:	Review
Published:	2014
Subjects:	CYP3A4 Drug interactions Drugs Mechanism-based inhibition Toxicity
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/106718
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Application of support vector machines to in silico prediction of cytochrome P450 enzyme substrates and inhibitors
by: Yap, C.W., et al.
Published: (2014)

Effect of CYP3A4 inducer dexamethasone on hepatotoxicity of lapatinib: Clinical and in vitro evidence
by: Teo, Y.L., et al.
Published: (2014)

Reversible time-dependent inhibition of cytochrome P450 enzymes by duloxetine and inertness of its thiophene ring towards bioactivation
by: Chan, C.Y., et al.
Published: (2014)

Interactions of herbs with cytochrome P450
by: Zhou, S., et al.
Published: (2014)

Structure-based virtual screening of CYP1A1 inhibitors: towards rapid tier-one assessment of potential developmental toxicants
by: Goh, Janice Jia Ni, et al.
Published: (2022)

Internet resources for proteins associated with drug therapeutic effects, adverse reactions and ADME
by: Ji, Z.L., et al.
Published: (2014)

Insights into the substrate specificity, inhibitors, regulation, and polymorphisms and the clinical impact of human cytochrome P450 1A2
by: Zhou, S.-F., et al.
Published: (2014)

METABOLIC ACTIVATION OF FIBROBLAST GROWTH FACTOR RECEPTOR INHIBITORS BY CYTOCHROME P450: MECHANISTIC INVESTIGATIONS INTO THE BIOCHEMICAL BASIS AND PHARMACOKINETIC IMPLICATIONS OF MECHANISM-BASED INACTIVATION
by: TANG WEI TAT LLOYD
Published: (2022)

Insights into the structure, function, and regulation of human cytochrome P450 1A2
by: Zhou, S.-F., et al.
Published: (2014)

EXPLORING THE ROLE OF PHARMACOKINETIC ALTERATIONS IN TYROSINE KINASE INHIBITORS (TKIS)-ASSOCIATED TOXICITIES
by: TEO YI LING
Published: (2015)

DISCOVERY OF NOVEL MICRO-RNGS AND ENDOGENOUS METABOLISED WHICH PREDICT DRUG METABOLISING ENZYME ACTIVITY (CYTOCHROME P450 AND UDP-GLUCURONOSYL TRANSFERASE) IN HUMAN SUBJECTS
by: HAN HWAN CHOUR
Published: (2020)

Functional polymorphisms of the cytochrome P450 1A2 (CYP1A2) gene and prolonged QTc interval in schizophrenia
by: Tay, J.K.X., et al.
Published: (2011)

Preclinical factors affecting the interindividual variability in the clearance of the investigational anti-cancer drug 5,6-dimethylxanthenone-4-acetic acid
by: Zhou, S., et al.
Published: (2014)

Prediction of herb-drug metabolic interactions: A simulation study
by: Zhou, S., et al.
Published: (2014)

Predicting pharmacokinetic herb-drug interactions
by: Zhou, S., et al.
Published: (2014)

Clinically significant drug-drug interactions between oral anticancer agents and nonanticancer agents: Profiling and comparison of two drug compendia
by: Wong, C.-M., et al.
Published: (2014)

Genetic polymorphisms of cytochrome P450 2B6 gene in Han Chinese
by: Guan, S., et al.
Published: (2014)

In silico search of putative adverse drug reaction related proteins as a potential tool for facilitating drug adverse effect prediction
by: Ji, Z.L., et al.
Published: (2014)

Multidrug resistance proteins (MRPs) and implication in drug development
by: Tian, Q., et al.
Published: (2014)

Troglitazone-induced hepatic necrosis in an animal model of silent genetic mitochondrial abnormalities
by: Ong, M.M.K., et al.
Published: (2011)

DELINEATING THE MECHANISMS OF CARDIAC ADVERSE EFFECTS OF DRONEDARONE: A ROLE OF CYP2J2
by: KARKHANIS ANEESH VIDYADHAR
Published: (2018)

Mitochondrial abnormalities-A link to idiosyncratic drug hepatotoxicity?
by: Boelsterli, U.A., et al.
Published: (2011)

Troglitazone-induced hepatic mitochondrial proteome expression dynamics in heterozygous Sod2+/- mice: Two-stage oxidative injury
by: Lee, Y.H., et al.
Published: (2014)

Troglitazone-induced hepatic mitochondrial proteome expression dynamics in heterozygous Sod2+/-mice: Two-stage oxidative injury
by: Lee, Y.H., et al.
Published: (2011)

Intra- and inter-ethnic differences in the allele frequencies of cytochrome P450 2B6 gene in Chinese
by: Guan, S., et al.
Published: (2014)

Effect of omeprazole on the hydroxylation of warfarin enantiomers in human: In-vitro studies with liver microsomes and cDNA-expressed cytochrome P450 isozymes
by: Zhou, Q., et al.
Published: (2014)

Clinical Impact of Drug-Drug Interaction Between Aspirin and Prednisolone at a Cancer Center
by: Koomanan, N., et al.
Published: (2014)

Molecular and functional characterization of drug-metabolizing enzymes and transporter expression in the novel spontaneously immortalized human hepatocyte line HC-04
by: Lim, P.L.K., et al.
Published: (2011)

Clinically relevant drug interactions between anticancer drugs and psychotropic agents
by: Yap, K.Y.-L., et al.
Published: (2014)

Prediction of pharmacokinetic drug-drug interactions causing atorvastatin-induced rhabdomyolysis using physiologically based pharmacokinetic modelling
by: Li, S., et al.
Published: (2021)

Effect of (N-Hydroxymethyl)-2-propylpentamide on rat hepatic cytochrome P450
by: Nareerat Ruksuntorn
Published: (2007)

The mitochondrial superoxide/thioredoxin-2/ask1 signaling pathway is critically involved in troglitazone-induced cell injury to human hepatocytes
by: Lim, P.I.K., et al.
Published: (2014)

Underlying mitochondrial dysfunction triggers flutamide-induced oxidative liver injury in a mouse model of idiosyncratic drug toxicity
by: Kashimshetty, R., et al.
Published: (2014)

Monitoring drug-protein interaction
by: Yang, X.-X., et al.
Published: (2014)

A role for xanthine oxidase in the loss of cytochrome P-450 evoked by interferon
by: Moochhala, S.M., et al.
Published: (2012)

Electronic database to detect drug-drug interactions between antidepressants and oral anticancer drugs from a cancer center in Singapore: Implications to clinicians
by: Chan, A., et al.
Published: (2014)

Genetic and environmental predictors of serum 25-hydroxyvitamin D concentrations among middle-aged and elderly Chinese in Singapore
by: Robien, K., et al.
Published: (2014)

Drug-drug interactions between oral antiepileptics and oral anticancer drugs: Implications to clinicians
by: Cheung, Y.T., et al.
Published: (2014)

Potential Determinants of Prescribers' Drug-Drug Interaction Knowledge
by: Ko, Y., et al.
Published: (2014)

Drug interactions monitoring in epileptic clinic at Neurological Institute
by: Sermsook Jantai
Published: (2009)